Patents by Inventor Xavier Pesesse

Xavier Pesesse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Osteogenic Differentiation of Bone Marrow Stem Cells and Mesenchymal Stem Cells Using a Combination of Growth Factors
    Publication number: 20200407688
    Abstract: The invention relates to methods for osteogenic differentiation of human bone marrow stem cells (BMSC) or mesenchymal stem cells (MSC), in particular using human plasma or serum and FGF and TGFB growth factors. The invention also provides the so-obtained cells and cell populations, as well as further products comprising such and uses thereof in bone therapy.
    Type: Application
    Filed: July 14, 2020
    Publication date: December 31, 2020
    Inventors: Cindy Badoer, Enrico Bastianelli, Xavier Pesesse
  • Human Bone-Forming Cells in the Treatment of Inflammatory Rheumatic Diseases
    Publication number: 20200032212
    Abstract: The invention relates to novel therapeutic uses of isolated bone-forming cells, particularly in the treatment of inflammatory rheumatic diseases.
    Type: Application
    Filed: October 5, 2019
    Publication date: January 30, 2020
    Inventors: Enrico Bastianelli, Cindy Badoer, Christelle Bizimungu, Xavier Pesesse
  • Novel Mensenchymal Stem Cells And Bone-Forming Cells
    Publication number: 20170290859
    Abstract: The invention relates to a new type of mesenchymal stem cells (MSC) which co-express at least one mesenchymal marker, preferably at least CD105 and CD34. Also provided are bone-forming cells having an analogous phenotype. The invention also provides the cells and cell populations, as well as further products comprising such and uses thereof in bone therapy.
    Type: Application
    Filed: May 7, 2017
    Publication date: October 12, 2017
    Inventors: Cindy Badoer, Enrico Bastianelli, Xavier Pesesse
  • Mesenchymal stem cells and bone-forming cells
    Patent number: 9371515
    Abstract: The invention relates to a new type of mesenchymal stem cells (MSC) which co-express at least one mesenchymal marker, preferably at least CD105 and CD34. Also provided are bone-forming cells having an analogous phenotype. The invention also provides the cells and cell populations, as well as further products comprising such and uses thereof in bone therapy.
    Type: Grant
    Filed: May 7, 2009
    Date of Patent: June 21, 2016
    Assignee: Bone Therapeutics S.A.
    Inventors: Cindy Badoer, Enrico Bastianelli, Xavier Pesesse
  • Human Bone-Forming Cells in the Treatment of Conditions and Bone Diseases Associated with Immunodeficiency or Immunosuppression
    Publication number: 20150164951
    Abstract: The invention relates to novel therapeutic uses of isolated bone-forming cells, particularly in the treatment of diseases and conditions associated with immunodeficiency or immunosuppression.
    Type: Application
    Filed: October 13, 2014
    Publication date: June 18, 2015
    Inventors: Valentina ALBARANI, Enrico BASTIANELLI, Cindy BADOER, Xavier PESESSE
  • TARGETS AND AGENTS FOR THE TREATMENT OF IMPAIRED BONE FRACTURE HEALING
    Publication number: 20140212380
    Abstract: The application teaches a composition comprising one or more pharmaceutical active ingredients selected from the group consisting of interleukin-8 (IL-8 or CXCL8), a functional fragment of IL-8, a functional variant of IL-8, and an agonist of IL-8 receptor, for therapeutic and/orprophylactic interventions in impaired bone fracture healing, such as but not limited to non-union fractures, mal-union fractures, or delayed union fractures.
    Type: Application
    Filed: June 11, 2012
    Publication date: July 31, 2014
    Applicants: Universite Libre De Bruxelles, Centre Hospitalier Universitaire de Liege, Universite de Liege, Bone Therapeutics SA
    Inventors: Valerie Gangji, Jean-Philippe Hauzeur, Dominique De Seny, Myrielle Mathieu, Aude Ingels, Sabrina Rigutto, Delphine Spruyt, Enrico Bastianelli, Valentina Albarani, Xavier Pesesse, Michel Malaise
  • MARKERS FOR IMPAIRED BONE FRACTURE HEALING
    Publication number: 20140100137
    Abstract: The present application discloses particularly interleukin-8 (IL-8) as a novel biomarker for the prediction, diagnosis, prognosis and/or monitoring of impaired bone fracture healing; and related methods, uses and kits.
    Type: Application
    Filed: June 11, 2012
    Publication date: April 10, 2014
    Applicants: Universite Libre De Bruxelles, Certre Hospitalier Universitaire de Liege, Universite de Liege, Bone Therapeutics SA
    Inventors: Valerie Gangji, Jean-Philippe Hauzeur, Dominique De Seny, Myrielle Mathieu, Aude Ingels, Sabrina Rigutto, Delphine Spruyt, Enrico Bastianelli, Valentina Albarari, Xavier Pesesse, Michel Malaise
  • Osteogenic Differentiation Of Bone Marrow Stem Cells And Mesenchymal Stem Cells Using A Combination Of Growth Factors
    Publication number: 20130266544
    Abstract: The invention relates to methods for osteogenic differentiation of human bone marrow stem cells (BMSC) or mesenchymal stem cells (MSC), in particular using human plasma or serum and FGF and TGFB growth factors. The invention also provides the so-obtained cells and cell populations, as well as further products comprising such and uses thereof in bone therapy.
    Type: Application
    Filed: March 13, 2013
    Publication date: October 10, 2013
    Inventors: Cindy Badoer, Enrico Bastianelli, Xavier Pesesse
  • Novel Mesenchymal Stem Cells and Bone-Forming Cells
    Publication number: 20110262404
    Abstract: The invention relates to a new type of mesenchymal stem cells (MSC) which co-express at least one mesenchymal marker, preferably at least CD105 and CD34. Also provided are bone-forming cells having an analogous phenotype. The invention also provides the cells and cell populations, as well as further products comprising such and uses thereof in bone therapy.
    Type: Application
    Filed: May 7, 2009
    Publication date: October 27, 2011
    Applicant: BONE THERAPEUTICS S.A.
    Inventors: Cindy Badoer, Enrico Bastianelli, Xavier Pesesse
  • HUMAN BONE-FORMING CELLS IN THE TREATMENT OF CONDITIONS AND BONE DISEASES ASSOCIATED WITH IMMUNODEFICIENCY OR IMMUNOSUPPRESSION
    Publication number: 20110064692
    Abstract: The invention relates to novel therapeutic uses of isolated bone-forming cells, particularly in the treatment of diseases and conditions associated with immunodeficiency or immunosuppression.
    Type: Application
    Filed: May 8, 2009
    Publication date: March 17, 2011
    Applicant: BONE THERAPEUTICS S.A.
    Inventors: Valentina Albarani, Enrico Bastianelli, Cindy Badoer, Xavier Pesesse
  • Osteogenic Differentiation Of Bone Marrow Stem Cells And Mesenchymal Stem Cells Using A Combination Of Growth Factors
    Publication number: 20100278788
    Abstract: The invention relates to methods for osteogenic differentiation of human bone marrow stem cells (BMSC) or mesenchymal stem cells (MSC), in particular using human plasma or serum and FGF and TGFB growth factors. The invention also provides the so-obtained cells and cell populations, as well as further products comprising such and uses thereof in bone therapy.
    Type: Application
    Filed: January 1, 2008
    Publication date: November 4, 2010
    Applicant: BONE THERAPEUTICS, S.A.
    Inventors: Cindy Badoer, Enrico Bastianelli, Xavier Pesesse
  • Human Bone-Forming Cells In The Treatment of Inflammatory Rheumatic Diseases
    Publication number: 20100272696
    Abstract: The invention relates to novel therapeutic uses of isolated bone-forming cells, particularly in the treatment of inflammatory rheumatic diseases.
    Type: Application
    Filed: December 19, 2008
    Publication date: October 28, 2010
    Applicant: BONE THERAPEUTICS S.A.
    Inventors: Enrico Bastianelli, Cindy Badoer, Christelle Bizimungu, Xavier Pesesse